Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Details about COVID-19, monkeypox, and the flu vaccine
New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
Get the iPhone MyHealth app »
Get the Android MyHealth app »
PMP-300E (Smart Watch): Portable Monitoring Device Study
Trial ID or NCT#
NCT01364740
Status
NOT RECRUITING
Purpose
Validation of Portable Monitoring Device PMP-300E for Identification of Obstructive Sleep Apnea.
Official Title
PMP-300E: Validation of Portable Monitoring Device PMP-300E for Identification of Obstructive Sleep Apnea.
Eligibility Criteria
Ages Eligible for Study: Older than 18 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No
Inclusion Criteria:
- Inclusion Criteria: - Age 18 and over. - Require a sleep diagnostic study by physician's order. - Able and willing to provide written informed consent. - Able to speak and read English.
Exclusion Criteria:
- Exclusion Criteria: - Participation in another interventional research study within the last 30 days. - Unstable medical or psychiatric conditions that would interfere with the demands of the study or the ability to commit to follow-up assessment. Examples include unstable congestive heart failure, neuromuscular disease, cancer, and renal failure. - Chronic respiratory failure or insufficiency with suspected or known neuromuscular disease, moderate or severe COPD or other pulmonary disorders, or any condition with an elevation of arterial carbon dioxide levels (> 45 mmHg) while awake or participants qualifying for oxygen therapy (arterial saturation 88% for more than five minutes). - Consumption of ethanol more than 4 nights per week. (CAGE criteria) - Use of recreational drug within the past 12 months. - Women who are pregnant or currently lactating.
Investigator(s)
Clete A. Kushida, MD, PhD
Sleep specialist,
Neurologist
Professor of Psychiatry and Behavioral Sciences (Sleep Medicine)
Contact us to find out if this trial is right for you.
CONTACT
Chia-Yu Cardell
(650) 721-7576
View on ClinicalTrials.gov
About this Clinical Trial
PMP-300E (Smart Watch): Portable Monitoring Device Study
Your Message Will Go To
Chia-Yu Cardell6507217576